Drug-eluting stent outcomes in diabetes

Chiara Bernelli, Jaclyn Chan, Alaide Chieffo

Research output: Contribution to journalArticlepeer-review


Diabetic population still remains a challenging subgroup of patients for percutaneous coronary intervention (PCI). However, with rapid advancements of PCI techniques, devices and adjunctive drug therapy, clinical outcomes for diabetic patients after PCI have markedly improved. The plethora of recent encouraging data with newer generation drug-eluting stent (DES), with a lower frequency of major cardiac adverse events, lead to an increasing use of DES in this particular high-risk population. However, diabetes remains an important risk factor for coronary events, even in the DES era. This review summarizes the outcomes in diabetic patients undergoing PCI with DES implantation.

Original languageEnglish
Pages (from-to)95-109
Number of pages15
JournalExpert Review of Cardiovascular Therapy
Issue number1
Publication statusPublished - Jan 2014


  • coronary artery disease
  • coronary stents
  • diabetes mellitus
  • drug-eluting stents
  • outcomes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine


Dive into the research topics of 'Drug-eluting stent outcomes in diabetes'. Together they form a unique fingerprint.

Cite this